TYGACIL 50 mg, poudre pour solution pour perfusion — 10 flacon(s) en verre de 50 mg

Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France

  • CIP13 3400956703203
  • CIP7 5670320
  • CIS 69265912
  • Registration number EU/1/06/336

What the source publishes

Holder
PFIZER EUROPE MA EEIG (BELGIQUE)
Active ingredients
TIGÉCYCLINE
Form
poudre pour solution pour perfusion
Package
10 flacon(s) en verre de 50 mg
Routes
intraveineuse
Administrative status
authorised
Supply regime
réservé à l'usage HOSPITALIER ; liste I
Marketing status
Déclaration de commercialisation
Authorised on
2006-04-24
Prescription
Prescription or restricted

Names this record is found by

Complete source data
fr:ansm:packages:3400956703203
{
  "cis": "69265912",
  "cip7": "5670320",
  "form": "poudre pour solution pour perfusion",
  "name": "TYGACIL 50 mg, poudre pour solution pour perfusion — 10 flacon(s) en verre de 50 mg",
  "cip13": "3400956703203",
  "holder": "PFIZER EUROPE MA EEIG (BELGIQUE)",
  "routes": [
    "intraveineuse"
  ],
  "holders": [
    "PFIZER EUROPE MA EEIG (BELGIQUE)"
  ],
  "currency": "EUR",
  "marketed": true,
  "bdmStatus": null,
  "useDomain": "unknown",
  "publicPrice": null,
  "authorisedOn": "2006-04-24",
  "compositions": [
    {
      "name": "TIGÉCYCLINE",
      "nature": "SA",
      "strength": "50 mg",
      "linkageNumber": "1",
      "substanceCode": "91931",
      "dosageReference": "un flacon",
      "pharmaceuticalElement": "poudre"
    }
  ],
  "sourceStatus": "Présentation active",
  "supplyRegime": "réservé à l'usage HOSPITALIER ; liste I",
  "dispensingFee": null,
  "medicinePrice": null,
  "regionalRules": "not-collected",
  "targetSpecies": [],
  "specialityName": "TYGACIL 50 mg, poudre pour solution pour perfusion",
  "marketingStatus": "Déclaration de commercialisation",
  "publicationDates": {
    "CIS_bdpm": "2026-01-08",
    "CIS_CIP_bdpm": "2026-11-19",
    "CIS_CPD_bdpm": "2026-01-08",
    "CIS_COMPO_bdpm": "2026-01-08"
  },
  "specialityListed": true,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "fr.ansm.bdpm"
  },
  "collectiveApproval": "oui",
  "packageDescription": "10 flacon(s) en verre de 50 mg",
  "patientEligibility": "not-assessed",
  "reimbursementRates": [],
  "marketingDeclaredOn": "2006-05-05",
  "targetSpeciesStatus": "not-reported",
  "additionalMonitoring": false,
  "administrativeStatus": "authorised",
  "prescriptionCategory": "prescription-or-restricted",
  "activeIngredientNames": [
    "TIGÉCYCLINE"
  ],
  "authorisationProcedure": "Procédure centralisée",
  "prescriptionConditions": [
    "réservé à l'usage HOSPITALIER",
    "liste I"
  ],
  "reimbursementIndications": null,
  "authorisationSourceStatus": "Autorisation active",
  "europeanAuthorisationNumber": "EU/1/06/336",
  "presentationAdministrativeStatus": "authorised"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=fr" \
  --data-urlencode "sourceId=fr.ansm.bdpm" \
  --data-urlencode "id=fr:ansm:packages:3400956703203"